Phagocytosis of Escherichia coli by amoeboid microglial cells in the developing brain

Area of Science:

• Neuroimmunology
• Cellular Biology

Background:

• Microglia are the primary immune cells of the central nervous system.
• Amoeboid microglial cells (AMC) are prevalent in the neonatal brain.
• The response of AMC to bacterial infection in the early postnatal period is not fully understood.

Purpose of the Study:

• To investigate the dynamic interaction between amoeboid microglial cells and Escherichia coli in the neonatal rat brain.
• To assess the capacity of AMC to clear bacterial pathogens in vivo.
• To examine the phenotypic changes in AMC following bacterial challenge.

Main Methods:

• Intracerebral injection of Escherichia coli into 1-day-old rats.
• Microscopic examination of corpus callosum tissue at various time points post-injection (1-3 hours, 1 day, 7 days).
• Assessment of bacterial internalization, phagosome presence, cell viability, cell counts, complement type 3 receptor expression, and major histocompatibility complex class II antigen induction.

Main Results:

• AMC rapidly internalized large numbers of E. coli within 1-3 hours.
• No viable E. coli were detected at 1 day post-injection, with large phagosomes observed.
• AMC populations remained stable, with no significant apoptosis or necrosis observed.
• Up-regulation of complement type 3 receptors and MHC class II antigens occurred at 1-7 days post-injection.

Conclusions:

• AMC possess a potent phagocytic capacity to clear live bacteria from the neonatal brain.
• AMC effectively eliminate E. coli without significant loss of cell population.
• Upregulation of complement receptors and MHC class II suggests a role in bacterial clearance and potential antigen presentation.